Erudio Healtherudio.com
Sponsor
AVEO Pharmaceuticals trials: what clinicians said in public
No HCP commentary report on a trial sponsored by AVEO Pharmaceuticals yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by AVEO Pharmaceuticals: TiNivo, TiNivo-2 and TIVO-3. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (AVEO Pharmaceuticals, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| TiNivo-2 NCT04987203 · AVEO Pharmaceuticals, Inc. DeepView → | renal cell carcinoma following an immune checkpoint inhibitor | Phase 3 | Deep | View | |||
| TIVO-3 NCT02627963 · AVEO Pharmaceuticals, Inc. DeepView → | relapsed/refractory advanced renal cell carcinoma | Phase 3 | Deep | View | |||
| TiNivo NCT03136627 · AVEO Pharmaceuticals, Inc. StandardView → | metastatic renal cell carcinoma | Phase 1/Phase 2 | Standard | View | |||